Multiomics Blood Biomarkers Predict Alzheimer from predementia with High Specificity
Benoît Souchet(AGCO (Netherlands)), Jérôme Braudeau, Juan Fortea(Hospital de Sant Pau), Alberto Lleó(Hospital de Sant Pau), Eloi Haudebourg(Evotec (United States)), Alkéos Michaïl, Colin L. Masters(Mental Health Research Institute), Suman Jayadev(University of Washington), Antoine Berthemy, François Mouton‐Liger(Inserm), Christopher Fowler(Florey Institute of Neuroscience and Mental Health), Baptiste Billoir, Claire Paquet(Université Paris Cité), Aude Dupuy‐Gayral(Evotec (United States)), Catherine Pech, Maud Heuillet, François Autelitano(Evotec (Germany))
Cited by 0
Related Papers
Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
|New England Journal of Medicine|2012|3.8k
Alzheimer's disease
|Nature Reviews Disease Primers|2015|1.8k
High performance plasma amyloid-β biomarkers for Alzheimer’s disease
|Nature|2018|1.7k